You are here

Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Anaheim, California, 92801 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Peptic Ulcers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
50-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A healthy adult between 50 and 75 years of age inclusive: of normal clinical
laboratory test results during the Screening Visit or, if abnormal, are not clinically
significant in the Investigator's opinion.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- A gastric, pyloric channel or duodenal ulcer (defined as any break in the mucosa at
least 3 mm in diameter with unequivocal depth) or more than 5 erosions in the stomach
or duodenum ( the UGI endoscopic score greater or less) on the baseline UGI endoscopy

NCT00137033
Pfizer
Completed
Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now